I am excited to announce that I will be participating in the Edinburgh Marathon 2025 to support Myeloma UK, a cause close to my heart. In 2024, my family received the devastating news that my aunt was diagnosed with multiple myeloma. Witnessing the strength, positivity and resilience of my aunt throughout her continuing journey has inspired me to take action. My goal is to raise £1000 for Myeloma UK, and every step I take during the marathon will be in honour of those who are fighting this battle. Together, we can make a difference in the lives of those affected by this disease.

Your contribution will not only help me reach my fundraising target but also provide vital resources for research, support, and awareness. Please donate generously to help fund lifesaving research and help those with multiple myeloma to continue to be supported and get the best possible treatment.

Thank you for taking the time to read, donate and support a cause that I am passionate to create a greater awareness for.

A bit about multiple myeloma:

Myeloma, also known as multiple myeloma, is a blood cancer arising from plasma cells. At any one time there are around 24,000 people living with myeloma in the UK. It accounts for 15 per cent of blood cancers, and two per cent of all cancers. Myeloma mainly affects those over the age of 65, however, it has been diagnosed in people much younger.

Treatment for myeloma can be very effective at controlling the disease, relieving its symptoms and complications, and prolonging life. Unfortunately, though, myeloma is currently an incurable cancer.

Although myeloma is not curable, it is not always considered terminal (something that cannot be cured and is likely to lead to someone’s death). There are a number of effective treatments for myeloma patients, which can control the cancer and prolong life. It’s difficult, if not impossible, to predict how long someone will live with myeloma, but many patients do respond to treatment and live with myeloma for a long time. The life expectancy of someone with myeloma has improved hugely and we have more treatment options available than ever before.

Myeloma is a relapsing-remitting cancer. This means there are periods when the myeloma is causing symptoms and/or complications and needs to be treated, followed by periods of remission or plateau where the myeloma does not cause symptoms and does not require treatment.